PMID- 31540489 OWN - NLM STAT- MEDLINE DCOM- 20200205 LR - 20200205 IS - 1420-3049 (Electronic) IS - 1420-3049 (Linking) VI - 24 IP - 18 DP - 2019 Sep 18 TI - Proanthocyanidin-Rich Fractions from Red Rice Extract Enhance TNF-alpha-Induced Cell Death and Suppress Invasion of Human Lung Adenocarcinoma Cell A549. LID - 10.3390/molecules24183393 [doi] LID - 3393 AB - Tumor necrosis factor-alpha (TNF-alpha) plays a key role in promoting tumor progression, such as stimulation of cell proliferation and metastasis via activation of NF-kappaB and AP-1. The proanthocyanidin-rich fraction obtained from red rice (PRFR) has been reported for its anti-tumor effects in cancer cells. This study investigated the molecular mechanisms associated with PRFR on cell survival and metastasis of TNF-alpha-induced A549 human lung adenocarcinoma. Notably, PRFR enhanced TNF-alpha-induced A549 cell death when compared with PRFP alone and caused a G0-G1 cell cycle arrest. Although, PRFR alone enhanced cell apoptosis, the combination treatment induced the cells that had been enhanced with PRFR and TNF-alpha to apoptosis that was less than PRFR alone and displayed a partial effect on caspase-8 activation and PARP cleavage. By using the autophagy inhibitor; 3-MA attenuated the effect of how PRFR enhanced TNF-alpha-induced cell death. This indicates that PRFR not only enhanced TNF-alpha-induced A549 cell death by apoptotic pathway, but also by induction autophagy. Moreover, PRFR also inhibited TNF-alpha-induced A549 cell invasion. This effect was associated with PRFR suppressed the TNF-alpha-induced level of expression for survival, proliferation, and invasive proteins. This was due to reduce of MAPKs, Akt, NF-kappaB, and AP-1 activation. Taken together, our results suggest that TNF-alpha-induced A549 cell survival and invasion are attenuated by PRFR through the suppression of the MAPKs, Akt, AP-1, and NF-kappaB signaling pathways. FAU - Subkamkaew, Chayaporn AU - Subkamkaew C AD - Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. subkamkaew@gmail.com. FAU - Limtrakul Dejkriengkraikul, Pornngarm AU - Limtrakul Dejkriengkraikul P AUID- ORCID: 0000-0003-4968-6667 AD - Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. AD - Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. AD - Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand. FAU - Yodkeeree, Supachai AU - Yodkeeree S AUID- ORCID: 0000-0001-9023-2283 AD - Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. yodkeelee@hotmail.com. AD - Anticarcinogenesis and Apoptosis Research Cluster, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. yodkeelee@hotmail.com. AD - Center for Research and Development of Natural Products for Health, Chiang Mai University, Chiang Mai 50200, Thailand. yodkeelee@hotmail.com. LA - eng GR - 096/2560/Faculty of Medicine, Chiang Mai University/ PT - Journal Article DEP - 20190918 PL - Switzerland TA - Molecules JT - Molecules (Basel, Switzerland) JID - 100964009 RN - 0 (Antineoplastic Agents, Phytogenic) RN - 0 (Neoplasm Proteins) RN - 0 (Plant Extracts) RN - 0 (Proanthocyanidins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 18206-61-6 (proanthocyanidin) SB - IM MH - A549 Cells MH - Adenocarcinoma of Lung/*metabolism/pathology MH - *Antineoplastic Agents, Phytogenic/chemistry/pharmacology MH - Autophagic Cell Death/*drug effects MH - Humans MH - Lung Neoplasms/*metabolism/pathology MH - MAP Kinase Signaling System/drug effects MH - Neoplasm Invasiveness MH - Neoplasm Proteins/metabolism MH - Oryza/*chemistry MH - *Plant Extracts/chemistry/pharmacology MH - *Proanthocyanidins/chemistry/pharmacology MH - Tumor Necrosis Factor-alpha/*pharmacology PMC - PMC6767152 OTO - NOTNLM OT - TNF-alpha OT - autophagy OT - invasion OT - lung adenocarcinoma OT - proanthocyanins COIS- The authors declare that they hold no conflicts of interest. EDAT- 2019/09/22 06:00 MHDA- 2020/02/06 06:00 PMCR- 2019/09/18 CRDT- 2019/09/22 06:00 PHST- 2019/08/23 00:00 [received] PHST- 2019/09/10 00:00 [revised] PHST- 2019/09/17 00:00 [accepted] PHST- 2019/09/22 06:00 [entrez] PHST- 2019/09/22 06:00 [pubmed] PHST- 2020/02/06 06:00 [medline] PHST- 2019/09/18 00:00 [pmc-release] AID - molecules24183393 [pii] AID - molecules-24-03393 [pii] AID - 10.3390/molecules24183393 [doi] PST - epublish SO - Molecules. 2019 Sep 18;24(18):3393. doi: 10.3390/molecules24183393.